Back to search

Article

Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NK-κβ/ERK/p38 signaling pathways

2024-01-24

Abstract excerpt

<title>Abstract</title> <p>Background Postmenopausal osteoporosis is a chronic metabolic bone disease caused by excessive osteoclast formation and function. Targeting osteoclast differentiation and activity can modulate bone resorption and alleviate osteoporosis. Cirsilineol, an active constituent of vestita Wall, has shown numerous biological activities and has been used to treat many metabolic diseases. Howeve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16720939-2285-50b9-b7a3-7ef0f77ec465
DOI
10.21203/rs.3.rs-3849118/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NK-κβ/ERK/p38 signaling pathwaysDOI 10.21203/rs.3.rs-3849118/v1
Select a neighboring publication to make it the new centre.